SCHEMBL7016782

SCHEMBL7016782

Cc1ccc(-c2ccccc2C(=O)N(C)NC(N)=O)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.50
MEN1 O00255 2/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
ALDH1A1 P00352 2/20 0.43
BCAT2 O15382 1/20 0.42
KIF11 P52732 1/20 0.41
SLC6A3 Q01959 3/20 0.39
SLC6A4 P31645 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.38
TACR1 P25103 2/20 0.38
LTB4R2 Q9NPC1 1/20 0.37
ABCB1 P08183 1/20 0.37
LMNA P02545 1/20 0.37
NPC1 O15118 1/20 0.36
GAA P10253 1/20 0.36
RAB9A P51151 1/20 0.36
FPR2 P25090 1/20 0.36
TUBB4A P04350 1/20 0.36
TUBB P07437 1/20 0.36
TUBA3C P0DPH7 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7102292 0.80 KMT2A (0.57) KMT2AMEN1SMN1; SMN2ALDH1A1BCAT2
SCHEMBL6004326 0.76 BCAT2 (0.71) KMT2AMEN1SMN1; SMN2ALDH1A1BCAT2
SCHEMBL7007988 0.76 L3MBTL1 (0.48) KMT2AMEN1ALDH1A1BCAT2KIF11
SCHEMBL14134245 0.73 KEAP1 (0.54) KMT2AMEN1SMN1; SMN2ALDH1A1LTB4R2
SCHEMBL7374560 0.72 KMT2A (0.58) KMT2AMEN1SMN1; SMN2ALDH1A1BCAT2
SCHEMBL16882044 0.72 KMT2A (0.48) KMT2AMEN1SMN1; SMN2ALDH1A1BCAT2
SCHEMBL3491462 0.72 CTSD (0.53) ALDH1A1BCAT2SLC6A3SLC6A4L3MBTL1
SCHEMBL372 0.71 KMT2A (0.60) KMT2AMEN1SMN1; SMN2ALDH1A1BCAT2
SCHEMBL7745951 0.71 CHEK1 (0.49) KMT2AMEN1SMN1; SMN2ALDH1A1BCAT2
SCHEMBL31402608 0.71 KMT2A (0.60) KMT2AMEN1SMN1; SMN2ALDH1A1BCAT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0520423-B1 Heterocyclic compounds, their production and use as angiotensin II antagonists TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2003-05-14 EP disclosed
US-6100252-A SPECIFIED COMPOUNDS INCLUDING METHYL 2-BUTYL-1-((2'-(2-OXO-3H-1,2,3,5-OXATHIADIAZOL-4-YL)BIPHENYL) METHYL)-BENZIMIDAZOLE-7-CARBOXYLATE; USE TO TREAT CIRCULATORY DISEASES SUCH AS HYPERTENSIVE DISEASES AND HEART DISEASES TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2000-08-08 US disclosed
US-5883111-A STRONG AND LONG-LASTING ACTION BY ORAL ADMINISTRATION; HYPOTENSIVE AGENTS; CARDIOTONIC AGENTS; ALZHEIMER'S DISEASE; TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1999-03-16 US disclosed
US-5583141-A ADMINISTERING AS THERAPEUTIC AGENTS OF CIRCULATORY DISEASES; AZILSARTAN; ANGIOTENSIN II ANTAGONISTS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1996-12-10 US disclosed
US-5354766-A 2-Ethoxy-1-((2'(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl) biphenyl-4-yl)methyl)benzimidazole-7-carboxylic acid; hypotensive agents; CNS activity TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1994-10-11 US disclosed
US-5243054-A Hypotensive agents, cardiovascular disorders or nervous system disorders TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1993-09-07 US disclosed
EP-0520423-A2 Heterocyclic compounds, their production and use as angiotensin II antagonists TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1992-12-30 EP disclosed